ArticleInternational journal of molecular sciences2026

Targeting CD177: A Novel Therapeutic Strategy for NLRP3-Associated Autoinflammatory Diseases.

Yinghua Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.